• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用微流控抗体亲和分析技术测定复杂溶液中的抗体亲和力和浓度的方案。

Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling.

机构信息

Institute of Neuropathology, University of Zurich, 8091 Zurich, Switzerland.

Fluidic Analytics, Unit A, The Paddocks Business Centre, Cherry Hinton Road, Cambridge CB1 8DH, UK.

出版信息

STAR Protoc. 2023 Mar 17;4(1):102095. doi: 10.1016/j.xpro.2023.102095. Epub 2023 Feb 13.

DOI:10.1016/j.xpro.2023.102095
PMID:36853663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9925161/
Abstract

Conventional methods of measuring affinity are limited by artificial immobilization, large sample volumes, and homogeneous solutions. This protocol describes microfluidic antibody affinity profiling on complex human samples in solution to obtain a fingerprint reflecting both affinity and active concentration of the target protein. To illustrate the protocol, we analyze the antibody response in SARS-CoV-2 omicron-naïve samples against different SARS-CoV-2 variants of concern. However, the protocol and the technology are amenable to a broad spectrum of biomedical questions. For complete details on the use and execution of this protocol, please refer to Emmenegger et al. (2022), Schneider et al. (2022), and Fiedler et al. (2022)..

摘要

传统的亲和力测量方法受到人为固定化、大样本体积和均相溶液的限制。本方案描述了在溶液中对复杂的人类样本进行微流控抗体亲和力分析,以获得反映目标蛋白亲和力和有效浓度的指纹图谱。为了说明该方案,我们分析了针对不同关注的 SARS-CoV-2 变体的 SARS-CoV-2 奥密克戎初免样本中的抗体反应。然而,该方案和技术适用于广泛的生物医学问题。有关该方案使用和执行的完整详细信息,请参阅 Emmenegger 等人(2022 年)、Schneider 等人(2022 年)和 Fiedler 等人(2022 年)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/623f7da5eaa5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/3e29223065ab/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/5ca1f17be4e3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/cd9c54ba4c59/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/16fa4ae13ac8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/623f7da5eaa5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/3e29223065ab/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/5ca1f17be4e3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/cd9c54ba4c59/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/16fa4ae13ac8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc03/9958089/623f7da5eaa5/gr4.jpg

相似文献

1
Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling.使用微流控抗体亲和分析技术测定复杂溶液中的抗体亲和力和浓度的方案。
STAR Protoc. 2023 Mar 17;4(1):102095. doi: 10.1016/j.xpro.2023.102095. Epub 2023 Feb 13.
2
SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling.SARS-CoV-2 蛋白质组微阵列用于 COVID-19 患者血清分析。
STAR Protoc. 2022 Feb 28;3(2):101238. doi: 10.1016/j.xpro.2022.101238. eCollection 2022 Jun 17.
3
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2.微流控抗体亲和分析揭示记忆再激活和交叉反应在防御 SARS-CoV-2 中的作用。
ACS Infect Dis. 2022 Apr 8;8(4):790-799. doi: 10.1021/acsinfecdis.1c00486. Epub 2022 Mar 30.
4
Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex.SARS-CoV-2 mRNA 疫苗接种后的抗体亲和力成熟和跨变体活性:既往暴露和性别的影响。
EBioMedicine. 2021 Dec;74:103748. doi: 10.1016/j.ebiom.2021.103748. Epub 2021 Dec 10.
5
Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination.第三剂 mRNA 疫苗接种后对 SARS-CoV-2 奥密克戎 BA.1、BA.2 和 BA.3 的抗体亲和力和跨变体中和作用。
Nat Commun. 2022 Aug 8;13(1):4617. doi: 10.1038/s41467-022-32298-w.
6
A cell-based system combined with flow cytometry to evaluate antibody responses against SARS-CoV-2 transmembrane proteins in patients with COVID-19.一种基于细胞的系统与流式细胞术相结合,用于评估 COVID-19 患者体内针对 SARS-CoV-2 跨膜蛋白的抗体反应。
STAR Protoc. 2022 Feb 22;3(1):101229. doi: 10.1016/j.xpro.2022.101229. eCollection 2022 Mar 18.
7
Protocol for constructing large size human antibody heavy chain variable domain (V) library and selection of SARS-CoV-2 neutralizing antibody domains.构建人抗体重链可变区(V)文库的方案及 SARS-CoV-2 中和抗体结构域的筛选。
STAR Protoc. 2021 Sep 17;2(3):100617. doi: 10.1016/j.xpro.2021.100617. Epub 2021 May 29.
8
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma.微流控分析揭示了人类血浆中 SARS-CoV-2 抗体的广泛亲和力。
Life Sci Alliance. 2021 Nov 30;5(2). doi: 10.26508/lsa.202101270. Print 2022 Feb.
9
A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.一种基于三聚体 RBD 的马赛克型 COVID-19 疫苗候选物可诱导针对奥密克戎和其他 SARS-CoV-2 变体的强大中和作用。
Elife. 2022 Aug 25;11:e78633. doi: 10.7554/eLife.78633.
10
Facile isolation of high-affinity nanobodies from synthetic libraries using CDR-swapping mutagenesis.利用 CDR 交换突变技术从合成文库中轻松分离高亲和力纳米抗体。
STAR Protoc. 2022 Jan 20;3(1):101101. doi: 10.1016/j.xpro.2021.101101. eCollection 2022 Mar 18.

引用本文的文献

1
AntiFormer: graph enhanced large language model for binding affinity prediction.AntiFormer:用于结合亲和力预测的图增强大型语言模型。
Brief Bioinform. 2024 Jul 25;25(5). doi: 10.1093/bib/bbae403.

本文引用的文献

1
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region.对欧洲一个大型都市地区的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)血清流行率进行持续的人群水平监测。
iScience. 2023 Feb 17;26(2):105928. doi: 10.1016/j.isci.2023.105928. Epub 2023 Jan 4.
2
Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration.血清指纹将治疗性抗体的抗病毒活性与其亲和力和浓度联系起来。
Sci Rep. 2022 Nov 17;12(1):19791. doi: 10.1038/s41598-022-22214-z.
3
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants.
新冠病毒感染和疫苗接种均可诱导对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株产生高亲和力的跨谱系反应。
iScience. 2022 Aug 19;25(8):104766. doi: 10.1016/j.isci.2022.104766. Epub 2022 Jul 16.
4
Avidity in antibody effector functions and biotherapeutic drug design.抗体效应功能和生物治疗药物设计中的亲合力。
Nat Rev Drug Discov. 2022 Oct;21(10):715-735. doi: 10.1038/s41573-022-00501-8. Epub 2022 Jul 5.
5
Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.感染 SARS-CoV-2 后可富集抗凝血酶原自身抗体,并受针对 SARS-CoV-2 蛋白的抗体反应强度影响。
PLoS Pathog. 2021 Dec 3;17(12):e1010118. doi: 10.1371/journal.ppat.1010118. eCollection 2021 Dec.
6
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma.微流控分析揭示了人类血浆中 SARS-CoV-2 抗体的广泛亲和力。
Life Sci Alliance. 2021 Nov 30;5(2). doi: 10.26508/lsa.202101270. Print 2022 Feb.
7
Progress and challenges in mass spectrometry-based analysis of antibody repertoires.基于质谱的抗体库分析的进展与挑战
Trends Biotechnol. 2022 Apr;40(4):463-481. doi: 10.1016/j.tibtech.2021.08.006. Epub 2021 Sep 14.
8
LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies.淋巴细胞活化基因3(LAG3)在人和小鼠神经元中不表达,且不调节α-突触核蛋白病。
EMBO Mol Med. 2021 Sep 7;13(9):e14745. doi: 10.15252/emmm.202114745. Epub 2021 Jul 26.
9
Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum.抗体亲和力决定了患者血清中 SARS-CoV-2 刺突/ACE2 结合的抑制作用。
ACS Infect Dis. 2021 Aug 13;7(8):2362-2369. doi: 10.1021/acsinfecdis.1c00047. Epub 2021 Apr 20.
10
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies.动力学指纹可区分抗 Aβ 抗体的作用机制。
Nat Struct Mol Biol. 2020 Dec;27(12):1125-1133. doi: 10.1038/s41594-020-0505-6. Epub 2020 Sep 28.